Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance of common stock (in shares) at Dec. 31, 2021   72,027,743      
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 256,208 $ 7 $ 401,702 $ (3,463) $ (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (4,711)     (4,711)  
Stock-based compensation expense 7,570   7,570    
Vesting of restricted stock units (in shares)   52,252      
Common stock issued pursuant to acquisition (in shares)   4,212,246      
Common stock issued pursuant to acquisition 23,295 $ 1 23,294    
Net loss (36,639)       (36,639)
Ending balance of common stock (in shares) at Sep. 30, 2022   76,292,241      
Ending balance of stockholders' equity at Sep. 30, 2022 245,723 $ 8 432,566 (8,174) (178,677)
Beginning balance of common stock (in shares) at Jun. 30, 2022   76,239,989      
Beginning balance of stockholders' equity at Jun. 30, 2022 259,196 $ 8 429,547 (5,959) (164,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (2,215)     (2,215)  
Stock-based compensation expense 3,019   3,019    
Vesting of restricted stock units (in shares)   52,252      
Net loss (14,277)       (14,277)
Ending balance of common stock (in shares) at Sep. 30, 2022   76,292,241      
Ending balance of stockholders' equity at Sep. 30, 2022 $ 245,723 $ 8 432,566 (8,174) (178,677)
Beginning balance of common stock (in shares) at Dec. 31, 2022 76,292,241 76,292,241      
Beginning balance of stockholders' equity at Dec. 31, 2022 $ 180,672 $ 8 435,292 (6,390) (248,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 28     28  
Stock-based compensation expense 9,010   9,010    
Shares withheld related to net share settlement (in shares)   (134,713)      
Shares withheld related to net share settlement (185)   (185)    
Vesting of restricted stock units (in shares)   566,828      
Common stock issued pursuant to acquisition (in shares)   10,000,000      
Common stock issued pursuant to acquisition 14,700 $ 1 14,699    
Private offering and merger financing refund 231   231    
Net loss $ (133,350)       (133,350)
Ending balance of common stock (in shares) at Sep. 30, 2023 86,724,356 86,724,356      
Ending balance of stockholders' equity at Sep. 30, 2023 $ 71,106 $ 9 459,047 (6,362) (381,588)
Beginning balance of common stock (in shares) at Jun. 30, 2023   86,552,595      
Beginning balance of stockholders' equity at Jun. 30, 2023 163,031 $ 9 455,381 (6,132) (286,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (230)     (230)  
Stock-based compensation expense 3,435   3,435    
Vesting of restricted stock units (in shares)   171,761      
Private offering and merger financing refund 231   231    
Net loss $ (95,361)       (95,361)
Ending balance of common stock (in shares) at Sep. 30, 2023 86,724,356 86,724,356      
Ending balance of stockholders' equity at Sep. 30, 2023 $ 71,106 $ 9 $ 459,047 $ (6,362) $ (381,588)